Second lung cancers in patients after treatment for an initial lung cancer.
暂无分享,去创建一个
[1] B. Achinstein,et al. Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.
[2] H. Satoh,et al. Late Recurrence of Small-Cell Lung Cancer: A Case Report , 2000, American journal of clinical oncology.
[3] D. Ettinger,et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. , 1997, Journal of the National Cancer Institute.
[4] T. Zhukov,et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] J. Lafitte,et al. Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study , 1997 .
[6] Y. Yatabe,et al. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers. , 1997, The Journal of thoracic and cardiovascular surgery.
[7] B. Johnson,et al. Second lung cancers in patients successfully treated for lung cancer. , 1997, Seminars in oncology.
[8] J. Samet,et al. Molecular damage in the bronchial epithelium of current and former smokers. , 1997, Journal of the National Cancer Institute.
[9] D. Karp. Lung cancer chemoprevention and management of carcinoma in situ. , 1997, Seminars in oncology.
[10] J S Lee,et al. Clonal genetic alterations in the lungs of current and former smokers. , 1997, Journal of the National Cancer Institute.
[11] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[12] M. Noppen,et al. Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis. , 1996, Lung cancer.
[13] J. Herndon,et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.
[14] E. Shaw,et al. Genetic analysis of second primary lung cancers in patients surviving small cell lung cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] H. Ohmatsu,et al. Late recurrence of small-cell lung cancer: treatment and outcome. , 1996, Oncology.
[16] K. Naunheim,et al. Clinical surveillance testing after lung cancer operations. , 1995, The Annals of thoracic surgery.
[17] M. O'connor,et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? , 1995, The Annals of thoracic surgery.
[18] K. Naunheim,et al. Post‐Treatment Management Options for Patients with Lung Cancer , 1995, Annals of surgery.
[19] M. Kelley,et al. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. , 1995, Oncogene.
[20] A. Hagenbeek,et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. , 1995, Journal of the National Cancer Institute.
[21] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[22] L V Rubinstein,et al. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.
[23] M. Kelley,et al. TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract , 1995, International journal of cancer.
[24] H. Hansen,et al. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] J. Rutherford,et al. Second primary lung cancer. , 1995, The Annals of thoracic surgery.
[26] S. Luh,et al. Surgical treatment of second primary lung cancer: report of eight cases. , 1995, Journal of the Formosan Medical Association = Taiwan yi zhi.
[27] W. Curran,et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. , 1995, Journal of the National Cancer Institute.
[28] A D Oxman,et al. Systematic Reviews: Checklists for review articles , 1994 .
[29] M. Stovall,et al. Lung cancer risk and radiation dose among women treated for breast cancer. , 1994, Journal of the National Cancer Institute.
[30] D. Szymańska,et al. Risk of late recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC). , 1994, Lung cancer.
[31] A. Sakurada,et al. Multicentricity in resected occult bronchogenic squamous cell carcinoma. , 1994, The Annals of thoracic surgery.
[32] R. Hruban,et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.
[33] A. Neugut,et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers , 1994, Cancer.
[34] A. Hagenbeek,et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] G. Tavilla,et al. Multiple Primary Lung Cancers , 1994, The Thoracic and cardiovascular surgeon.
[36] L. Rubinstein,et al. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. The Lung Cancer Study Group. , 1993, The Journal of thoracic and cardiovascular surgery.
[37] M. Hollstein,et al. Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.
[38] M. Tucker,et al. Smoking Cessation after Successful Treatment of Small-Cell Lung Cancer Is Associated with Fewer Smoking-related Second Primary Cancers , 1993, Annals of Internal Medicine.
[39] M Buyse,et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] A E Profio,et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. , 1993, The Journal of thoracic and cardiovascular surgery.
[41] P. Postmus,et al. Long term survival of small cell lung cancer patients after chemotherapy. , 1993, British Journal of Cancer.
[42] L. Faber. Resection for second and third primary lung cancer. , 1993, Seminars in surgical oncology.
[43] S. Hirohashi,et al. Application of the p53 Gene Mutation Pattern for Differential Diagnosis of Primary Versus Metastatic Lung Carcinomas , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[44] S. Kvaløy,et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] M. Oda,et al. Second surgical intervention for recurrent and second primary bronchogenic carcinomas. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.
[46] J P Pignon,et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.
[47] N. Day,et al. Lung cancer following Hodgkin′s disease: A case‐control study , 1992, International journal of cancer.
[48] S. Lippman,et al. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] M. Lishner,et al. Second primary malignancies following diagnosis of small-cell lung cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] P. Ganly,et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. , 1992, Oncogene.
[51] K. Maclennan,et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. , 1992, BMJ.
[52] M. Burt,et al. Multiple primary lung carcinomas: prognosis and treatment. , 1991, The Annals of thoracic surgery.
[53] Y. Ichinose,et al. DNA ploidy patterns of tumors diagnosed as metachronous or recurrent lung cancers. , 1991, Annals of Thoracic Surgery.
[54] J. Crowley,et al. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. , 1991, Chest.
[55] L. Garfinkel,et al. Lung cancer and smoking trends in the United States over the past 25 years , 1991, CA: a cancer journal for clinicians.
[56] P. Pairolero,et al. Multiple primary lung cancers. Results of surgical treatment. , 1990, The Journal of thoracic and cardiovascular surgery.
[57] R. Souhami,et al. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. , 1990, British Journal of Cancer.
[58] B. Corrin,et al. Second primary lung cancer: importance of long term follow up. , 1989, Thorax.
[59] M. Fukuoka,et al. Three-year disease-free survivors of small cell lung cancer treated with combination chemotherapy with or without chest irradiation. , 1989, European journal of cancer & clinical oncology.
[60] R. Tsuchiya,et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.
[61] M. Tucker,et al. Risk of second cancers after treatment for Hodgkin's disease. , 1988, The New England journal of medicine.
[62] D. Xie,et al. Multiple primary lung cancers. , 1987, Chest.
[63] S. Rodenhuis,et al. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.
[64] C. Mountain,et al. A new international staging system for lung cancer. , 1987, Chest.
[65] S. Tsugane,et al. Case-control study on histologically determined multiple primary lung cancer. , 1987, Journal of the National Cancer Institute.
[66] C. Mulrow. The medical review article: state of the science. , 1987, Annals of internal medicine.
[67] P. Pairolero,et al. Pulmonary aspergilloma. Results of surgical treatment. , 1986, The Journal of thoracic and cardiovascular surgery.
[68] H. Hansen,et al. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] R. Makuch,et al. Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer. , 1986, The American journal of medicine.
[70] D. Ettinger,et al. Long-term survivors of small cell carcinoma of the lung. , 1985, The American journal of medicine.
[71] D. Mathisen,et al. Survival following resection for second and third primary lung cancers. , 1984, The Journal of thoracic and cardiovascular surgery.
[72] E. Bergstralh,et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. , 1984, The Annals of thoracic surgery.
[73] H. Muss,et al. Second primary bronchogenic carcinomas after small cell carcinoma. Report of two cases and review of the literature. , 1984, The American journal of medicine.
[74] W F Taylor,et al. Survival of patients surgically treated for stage I lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.
[75] R. Smith,et al. Second primary lung carcinoma. , 1976, Thorax.
[76] H. Urschel,et al. Dual primary bronchogenic carcinoma. , 1974, The Annals of thoracic surgery.
[77] F. Woods,et al. Reoperation for bronchogenic carcinoma. , 1966, The Journal of thoracic and cardiovascular surgery.
[78] A. Horwich,et al. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. , 1997, British Journal of Cancer.
[79] Douglas L. Weed,et al. Methodologic Guidelines for Review Papers , 1997 .
[80] A. Chella,et al. Second primary lung cancer and relapse: treatment and follow-up. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[81] M E Burt,et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.
[82] P. Okunieff,et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] P. Radice,et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. , 1995, Cancer research.
[84] S. Lam,et al. Reprints Available Directly from the Publisher Photocopying Permitted by License Only Early Localization of Bronchogenic Carcinoma , 2022 .
[85] G. Mcelvaney,et al. Multiple primary bronchogenic carcinomas: treatment and follow-up. , 1991, The Annals of thoracic surgery.
[86] P. Warde,et al. Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung - A meta-analysis , 1990 .
[87] R. C. Chiu,et al. Second primary bronchogenic carcinoma: life-table analysis of surgical treatment. , 1979, The Annals of thoracic surgery.